UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 173

Sortiert nach

The Ubiquitin-Proteasome Pathway and Its Role in Cancer

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4776-4789

2005

Link zum Volltext

Verfügbarkeit prüfen

Molecular Biology of the Androgen Receptor

Journal of clinical oncology, 2002-07, Vol.20 (13), p.3001-3015

GELMANN, Edward P

2002

Link zum Volltext

Verfügbarkeit prüfen

NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage

Cancer research (Chicago, Ill.), 2015-07, Vol.75 (13), p.2686-2698

2015

Link zum Volltext

Verfügbarkeit prüfen

NKX3.1 activates cellular response to DNA damage

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8), p.3089-3097

2010

Link zum Volltext

Verfügbarkeit prüfen

Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression

PloS one, 2018-10, Vol.13 (10), p.e0205837-e0205837

2018

Link zum Volltext

Verfügbarkeit prüfen

Functional activation of ATM by the prostate cancer suppressor NKX3.1

Cell reports (Cambridge), 2013-08, Vol.4 (3), p.516-529

2013

Link zum Volltext

Verfügbarkeit prüfen

Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Cancer epidemiology, biomarkers & prevention, 2007-05, Vol.16 (5), p.962-968

2007

Link zum Volltext

Verfügbarkeit prüfen

Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer

Cancer medicine (Malden, MA), 2022-07, Vol.11 (13), p.2687-2698

2022

Link zum Volltext

Verfügbarkeit prüfen

Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (4), p.1164-1173

2005

Link zum Volltext

Verfügbarkeit prüfen

Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence

Clinical cancer research, 2005-08, Vol.11 (16), p.5863-5868

2005

Link zum Volltext

Verfügbarkeit prüfen

β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription

Molecular and Cellular Biology, 2003-03, Vol.23 (5), p.1674-1687

2003

Link zum Volltext

Verfügbarkeit prüfen

Methods for etiologic and early marker investigations in the PLCO trial

Mutation research, 2005-12, Vol.592 (1-2), p.147

2005

Link zum Volltext

Verfügbarkeit prüfen

Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression

Cancer research (Chicago, Ill.), 2019-08, Vol.79 (16), p.4124-4134

2019

Link zum Volltext

Verfügbarkeit prüfen

Renal Cell Cancer Treated with a Single-Edged Sword

Cell reports (Cambridge), 2013-02, Vol.3 (2), p.275-276

2013

Link zum Volltext

Verfügbarkeit prüfen

The expanding role of hormones in cancer

Endocrine oncology, 2021-02, Vol.1 (1), p.E1-E2

Gelmann, Edward P

2021

Link zum Volltext

Verfügbarkeit prüfen

Mortality Results from a Randomized Prostate-Cancer Screening Trial

The New England journal of medicine, 2009-03, Vol.360 (13), p.1310-1319

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression of NKX3.1 in normal and malignant tissues

The Prostate, 2003-05, Vol.55 (2), p.111-117

2003

Link zum Volltext

Verfügbarkeit prüfen

CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss

Cancer research (Chicago, Ill.), 2020-11, Vol.80 (21), p.4805-4814

2020

Link zum Volltext

Verfügbarkeit prüfen

Nkx3.1 controls the DNA repair response in the mouse prostate

The Prostate, 2016-03, Vol.76 (4), p.402-408

2016

Link zum Volltext

Verfügbarkeit prüfen

P53 gene mutations: Case study of a clinical marker for solid tumors

Seminars in oncology, 2002-06, Vol.29 (3), p.246-257

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of the Prostate in the Presence of Metastases: Lessons from Other Solid Tumors

European urology, 2016-05, Vol.69 (5), p.795-796

2016

Link zum Volltext

Verfügbarkeit prüfen

Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

Controlled clinical trials, 2000-12, Vol.21 (6), p.273S-309S

2000

Link zum Volltext

Verfügbarkeit prüfen

Complexities of Prostate-Cancer Risk

The New England journal of medicine, 2008-02, Vol.358 (9), p.961-963

Gelmann, Edward P

2008

Link zum Volltext

Verfügbarkeit prüfen

Cross-regulation of signaling pathways: An example of nuclear hormone receptors and the canonical Wnt pathway

Experimental cell research, 2010-07, Vol.316 (11), p.1763-1772

2010

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Cytokines Induce Phosphorylation and Ubiquitination of Prostate Suppressor Protein NKX3.1

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (17), p.6896-6901

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Englisch
(173)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Ubiquitin-Proteasome Pathway and Its Role in Cancer

Molecular Biology of the Androgen Receptor

NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage

NKX3.1 activates cellular response to DNA damage

Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression

Functional activation of ATM by the prostate cancer suppressor NKX3.1

Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer

Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer

Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence

β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription

Methods for etiologic and early marker investigations in the PLCO trial

Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression

Renal Cell Cancer Treated with a Single-Edged Sword

The expanding role of hormones in cancer

Mortality Results from a Randomized Prostate-Cancer Screening Trial

Expression of NKX3.1 in normal and malignant tissues

CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss

Nkx3.1 controls the DNA repair response in the mouse prostate

P53 gene mutations: Case study of a clinical marker for solid tumors

Treatment of the Prostate in the Presence of Metastases: Lessons from Other Solid Tumors

Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

Complexities of Prostate-Cancer Risk

Cross-regulation of signaling pathways: An example of nuclear hormone receptors and the canonical Wnt pathway

Inflammatory Cytokines Induce Phosphorylation and Ubiquitination of Prostate Suppressor Protein NKX3.1

Suchergebnisse filtern